Earnings History Data for Athira Pharma (ATHA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Athira Pharma

Athira Pharma Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Athira Pharma Inc. is based in SEATTLE.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		ATHA	Athira Pharma	29.00	-0.75	-0.80	0.00	Athira Pharma GAAP EPS of -$0.75 misses by $0.04 [11/8/2024 12:24 AM]	0.65	-0.10 (-13.33%)	0.72	-0.03 (-4.00%)	0.41 - 4.30	1,522,113	27,290,000	180,335
Athira Pharma GAAP EPS of -$0.75 misses by $0.04 [11/8/2024 12:24 AM]
01-08-2024	AH		ATHA	Athira Pharma	126.00	-0.70	-0.75	0.00	Athira Pharma GAAP EPS of -$0.70 beats by $0.04 [8/1/2024 5:40 PM]	3.21	-0.04 (-1.23%)	3.55	0.30 (9.20%)	1.33 - 4.30	41,173	80,000	3,752
Athira Pharma GAAP EPS of -$0.70 beats by $0.04 [8/1/2024 5:40 PM]
15-05-2024	AH		ATHA	Athira Pharma	89.00	-0.69	-0.80	0.00	Athira Pharma GAAP EPS of -$0.69 [5/15/2024 5:03 PM]	2.71	0.50 (22.40%)	2.30	0.09 (4.07%)	1.33 - 4.30	439,880	150,000	4,959
Athira Pharma GAAP EPS of -$0.69 [5/15/2024 5:03 PM]
22-02-2024	AH		ATHA	Athira Pharma	150.00	-0.71	-0.96	0.00	Athira Pharma GAAP EPS of -$3.09 beats by $0.25 [2/22/2024 5:07 PM]	3.92	-0.01 (-0.25%)	3.90	-0.03 (-0.76%)	1.33 - 4.30	261,431	350,000	1,124
Athira Pharma GAAP EPS of -$3.09 beats by $0.25 [2/22/2024 5:07 PM]
24-03-2022	AH	4:05 PM ET (Mar 24)	ATHA	Athira Pharma, Inc.	418.33	-0.37	-0.61	-0.24	Athira Pharma GAAP EPS of -$1.49 beats by $0.13 [3/24/2022 4:17 PM]	12.75	0.88 (7.41%)	12.00	0.13 (1.10%)	8.51 - 23.64	410,889	273,124	276
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update [Mar-24-22 04:05PM]
10-11-2021	AH		ATHA	Athira Pharma	578.00	-0.42	-0.50	0.00	Athira Pharma EPS beats by $0.08 [11/10/2021 4:49 PM]	16.40	1.54 (10.33%)	14.50	-0.36 (-2.42%)	8.88 - 34.79	695,690	600,000	55,947
Athira Pharma EPS beats by $0.08 [11/10/2021 4:49 PM] Athira eyes top-line data from phase 2 trial of Alzheimer's candidate in 1H 2022 [11/10/2021 12:13 PM] Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update [Nov-10-21 04:05PM] Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimers Disease at CTAD Conference [Nov-10-21 11:50AM]
16-08-2021	AH		ATHA	Athira Pharma, Inc.	373.00	-0.38	-0.37	0.00		9.17	-0.05 (-0.54%)	9.18	-0.04 (-0.43%)	8.88 - 34.79	760,689	350,000	706
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update [Aug-16-21 04:01PM] ATHA, RKT, ZY SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set [Aug-16-21 01:40PM] AUGUST 20 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-16-21 12:05PM] DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [Aug-16-21 11:40AM] ATHA, RKT & REKR Class Action Deadline Reminders: Bronstein, Gewirtz & Grossman LLC [Aug-16-21 11:00AM] FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-16-21 10:47AM] CLASS ACTION UPDATE for JRVR, ATHA and REKR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-16-21 10:15AM] ATHA EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Athira Pharma, Inc. [Aug-16-21 10:07AM] ATHA 8-DAY DEADLINE ALERT: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firms Attorneys Now, Securities Class Action Pending [Aug-16-21 09:36AM] Wolf Popper LLP Reminds Athira Pharma, Inc. (ATHA) Investors of August 24, 2021 Lead Plaintiff Filing Deadline [Aug-16-21 07:00AM] Lawsuits Filed Against ATHA, BZ and CRMD - Jakubowitz Law Pursues Shareholders Claims [Aug-16-21 05:40AM] SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ATHA, ATVI, RKT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits [Aug-16-21 10:50PM] Athira Pharma, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm [Aug-17-21 08:00AM] ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser [Aug-17-21 09:00AM] DEADLINE ALERT for TEDU, ATHA, REKR, ZY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders [Aug-17-21 11:00AM] SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-17-21 11:17AM] SHAREHOLDER ALERT: SRAC ATHA ITRM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines [Aug-17-21 12:40PM] Final Deadline Approaching on August 24, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Athira Pharma, Inc. Investors of Class Action Lawsuit Deadline [Aug-17-21 01:08PM] ATHA 7-DAY DEADLINE ALERT: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm's Attorneys Now, Investor Deadline Approaching in Securities Class Action [Aug-17-21 02:20PM] CLASS ACTION UPDATE for ATHA, AHCO and LIVE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-17-21 02:25PM] ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 24 Deadline in Securities Class Action ATHA [Aug-17-21 03:30PM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATHA, BLCT and PHG [Aug-17-21 07:20PM] FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm [Aug-17-21 06:00PM] Athira Deadline Alert [Aug-17-21 05:32PM] INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of ATHA, RKT, ZY Investors, Lead Plaintiff Deadlines Set [Aug-17-21 04:15PM]
13-05-2021	AH		ATHA	Athira Pharma, Inc.	656.00	-0.25	-0.30	0.00	Athira Pharma EPS beats by $0.05 [5/13/2021 5:23 PM]	18.10	0.02 (0.11%)	18.08	0.0 (0.00%)	15.79 - 34.79	217,585	170,000	811
Athira Pharma EPS beats by $0.05 [5/13/2021 5:23 PM] Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights [May-13-21 04:02PM]
25-03-2021	AH		ATHA	Athira Pharma, Inc.	675.71	-0.24	-0.29	0.00	Athira Pharma reports Q4 results [3/25/2021 4:49 PM]	17.98	0.02 (0.11%)	18.85	0.89 (4.96%)	15.79 - 34.79	256,755	280,000	762
Athira Pharma reports Q4 results [3/25/2021 4:49 PM] Athira Pharma to Present at Stifels 3rd Annual CNS Conference [Mar-24-21 07:00AM] Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights [Mar-25-21 04:02PM]